---
title: "Vland Biotech: Two jointly filed products have obtained new veterinary drug registration certificates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245647808.md"
description: "Vland Biotech announced that it and its wholly-owned subsidiary have jointly applied for two new veterinary drug products that have obtained registration certificates. These include the \"Porcine Pseudorabies Virus Gene-Deleted Inactivated Vaccine (CY-6 Strain)\" and the \"Chicken Newcastle Disease, Avian Influenza (H9 Subtype), and Avian Adenovirus Disease (Group 4 Type) Trivalent Inactivated Vaccine (LaSota Strain + TA Strain + LC Strain)\", both approved as Class III new veterinary drugs"
datetime: "2025-06-23T08:14:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245647808.md)
  - [en](https://longbridge.com/en/news/245647808.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245647808.md)
---

# Vland Biotech: Two jointly filed products have obtained new veterinary drug registration certificates

According to the Zhitong Finance APP, Vland Biotech (603739.SH) announced that the "Porcine Pseudorabies Virus Gene-Deleted Inactivated Vaccine (CY-6 Strain)" jointly applied for by the company and its wholly-owned subsidiaries, Qingdao Animal Health National Engineering Research Center Co., Ltd. and Qingdao Vland Animal Health Group Co., Ltd., along with other units, has been classified as a Class III new veterinary drug; the "Newcastle Disease, Avian Influenza (H9 subtype), and Avian Adenovirus Disease (Group 1 Type 4) Trivalent Inactivated Vaccine (LaSota Strain + TA Strain + LC Strain)" jointly applied for by the company and its wholly-owned subsidiaries, Qingdao Animal Health National Engineering Research Center Co., Ltd. and Qingdao Vland Animal Health Group Co., Ltd., along with other units, has also been classified as a Class III new veterinary drug, and the "New Veterinary Drug Registration Certificate" has been issued recently

### Related Stocks

- [603739.CN](https://longbridge.com/en/quote/603739.CN.md)

## Related News & Research

- [ZAWYA: Al Habtoor Tower: Dubai's boldest residential project yet](https://longbridge.com/en/news/287051508.md)
- [ZAWYA: UAE developers accelerate shift to recurring income amid market uncertainty](https://longbridge.com/en/news/287012545.md)
- [Post Oak Energy Capital Announces Sale of UpCurve Energy Assets](https://longbridge.com/en/news/287062130.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)